Mergers & AcquisitionsRichter and Hetero Team Up on Generic Semaglutide for Global Markets Richter and Hetero Team Up on Generic Semaglutide for Global Markets Read Post »
Health Tidings Mergers & AcquisitionsServier, n-Lorem Launch ASO Research Partnership in Rare Neurology Servier, n-Lorem Launch ASO Research Partnership in Rare Neurology Read Post »
Health Tidings Mergers & AcquisitionsNovartis Expands Orionis Partnership in $1.4 Billion Molecular Glue Drug Di... Novartis Expands Orionis Partnership in $1.4 Billion Molecular Glue Drug Di... Read Post »
Health Tidings Mergers & AcquisitionsLilly Signs Potential $1 Billion Alzheimer’s Deal With AlzeCure Lilly Signs Potential $1 Billion Alzheimer’s Deal With AlzeCure Read Post »
Health Tidings Mergers & AcquisitionsGSK Acquires Nuvalent, Adding FDA-Reviewed ROS1 and ALK Inhibitors GSK Acquires Nuvalent, Adding FDA-Reviewed ROS1 and ALK Inhibitors Read Post »
Mergers & AcquisitionsJohnson & Johnson Acquires Firefly Bio in $1 Billion Oncology Deal Johnson & Johnson Acquires Firefly Bio in $1 Billion Oncology Deal Read Post »
Health Tidings Mergers & AcquisitionsRoche Licenses Nurix’s BTK Degrader Bexobrutideg in Up to $2.3 Billion De... Roche Licenses Nurix’s BTK Degrader Bexobrutideg in Up to $2.3 Billion De... Read Post »
Health Tidings Mergers & AcquisitionsIncyte Bolsters Hematology Growth With $2 Billion Vega Buyout Incyte Bolsters Hematology Growth With $2 Billion Vega Buyout Read Post »
Mergers & AcquisitionsAlnylam Partners With Inceptive in Up to $2 Billion AI Drug Discovery Deal Alnylam Partners With Inceptive in Up to $2 Billion AI Drug Discovery Deal Read Post »
Health Tidings Mergers & AcquisitionsIDEAYA and Roche Advance PRMT5 and Pan-RAS Inhibitors in Pancreatic Cancer IDEAYA and Roche Advance PRMT5 and Pan-RAS Inhibitors in Pancreatic Cancer Read Post »
Health Tidings Mergers & AcquisitionsAscidian Secures Up to $1.9 Billion in Lilly Kidney Disease Partnership Ascidian Secures Up to $1.9 Billion in Lilly Kidney Disease Partnership Read Post »
Health Tidings Mergers & AcquisitionsCytomX Secures Expanded Regeneron Partnership Worth Up to $4 Billion CytomX Secures Expanded Regeneron Partnership Worth Up to $4 Billion Read Post »
Health Tidings Mergers & AcquisitionsCEPI Backs Moderna’s Bundibugyo Ebola Vaccine with $50 Million CEPI Backs Moderna’s Bundibugyo Ebola Vaccine with $50 Million Read Post »
Health Tidings Mergers & AcquisitionsServier Acquires Edgewise Muscular Dystrophy Business for Up to $2.65 Billi... Servier Acquires Edgewise Muscular Dystrophy Business for Up to $2.65 Billi... Read Post »
Mergers & AcquisitionsAgios Lands Global Cevidoplenib Rights in Rare Hematology Push Agios Lands Global Cevidoplenib Rights in Rare Hematology Push Read Post »
Health Tidings Mergers & AcquisitionsPfizer and Innovent Strike Oncology Deal Worth Up to $10.5 Billion Pfizer and Innovent Strike Oncology Deal Worth Up to $10.5 Billion Read Post »
Health Tidings Mergers & AcquisitionsApogee Secures Up to $1.3 Billion From Blackstone to Advance Zumilokibart i... Apogee Secures Up to $1.3 Billion From Blackstone to Advance Zumilokibart i... Read Post »
Health Tidings Mergers & AcquisitionsLilly Acquires Curevo, LimmaTech, and Vaccine Company to Expand Vaccine Por... Lilly Acquires Curevo, LimmaTech, and Vaccine Company to Expand Vaccine Por... Read Post »
Regulatory & Health PolicyChugai Wins Japan’s Top Invention Honor for Antibody Recycling Technology Chugai Wins Japan’s Top Invention Honor for Antibody Recycling Technology Read Post »
Regulatory & Health PolicyMHRA Proposes Accelerated Pathway for Rare Disease Therapies MHRA Proposes Accelerated Pathway for Rare Disease Therapies Read Post »
Mergers & AcquisitionsGilead Renews WHO Partnership to Fight Visceral Leishmaniasis Gilead Renews WHO Partnership to Fight Visceral Leishmaniasis Read Post »
Health Tidings Mergers & AcquisitionsJohnson & Johnson Builds AI-Powered Surgical Network in Abu Dhabi Johnson & Johnson Builds AI-Powered Surgical Network in Abu Dhabi Read Post »
Health Tidings Mergers & AcquisitionsBMS Integrates Claude AI into Research, Clinical Development, and Manufactu... BMS Integrates Claude AI into Research, Clinical Development, and Manufactu... Read Post »
Mergers & AcquisitionsIncyte Expands Molecular AI Collaboration With Genesis Therapeutics Incyte Expands Molecular AI Collaboration With Genesis Therapeutics Read Post »
Mergers & AcquisitionsHansa Licenses IDEFIRIX Rights to SERB in €115 Million Deal Hansa Licenses IDEFIRIX Rights to SERB in €115 Million Deal Read Post »
Mergers & AcquisitionsIncyte Collaborates With Edison Scientific on AI-Driven Drug Discovery Incyte Collaborates With Edison Scientific on AI-Driven Drug Discovery Read Post »
Mergers & AcquisitionsRegeneron and Parabilis Partner to Develop Antibody-Helicon Conjugates Regeneron and Parabilis Partner to Develop Antibody-Helicon Conjugates Read Post »
Health Tidings Mergers & AcquisitionsImmunityBio Secures Exclusive U.S. Rights to Tokyo-172 BCG for Bladder Canc... ImmunityBio Secures Exclusive U.S. Rights to Tokyo-172 BCG for Bladder Canc... Read Post »
Health Tidings Mergers & AcquisitionsEli Lilly and UNICEF USA Strengthen Childhood NCD Care in LMICs Eli Lilly and UNICEF USA Strengthen Childhood NCD Care in LMICs Read Post »
Health Tidings Mergers & AcquisitionsEnodia Therapeutics Acquires Sec61-Based Assets from Kezar Life Sciences Enodia Therapeutics Acquires Sec61-Based Assets from Kezar Life Sciences Read Post »
Regulatory & Health PolicyFDA Seeks Public Input on Drug Repurposing Opportunities FDA Seeks Public Input on Drug Repurposing Opportunities Read Post »
Mergers & AcquisitionsBoehringer Ingelheim Licenses Preclinical Antibody from Immunitas for Infla... Boehringer Ingelheim Licenses Preclinical Antibody from Immunitas for Infla... Read Post »
Mergers & AcquisitionsRigel Acquires Global Rights to Arvinas and Pfizer’s VEPPANU Rigel Acquires Global Rights to Arvinas and Pfizer’s VEPPANU Read Post »
Health Tidings Mergers & AcquisitionsBMS and Hengrui Forge a $15.2 Billion Drug Discovery Alliance BMS and Hengrui Forge a $15.2 Billion Drug Discovery Alliance Read Post »
Health Tidings Mergers & AcquisitionsGSK Aligns With CTTQ to Expand Access to Bepirovirsen in China GSK Aligns With CTTQ to Expand Access to Bepirovirsen in China Read Post »
Health Tidings Mergers & AcquisitionsOncotelic-Lunai N2B Deal Gains Momentum Amid Rising Focus on CNS Drug Deliv... Oncotelic-Lunai N2B Deal Gains Momentum Amid Rising Focus on CNS Drug Deliv... Read Post »
Regulatory & Health PolicyFDA Lays the Groundwork for Better Pregnancy Drug Safety Evidence FDA Lays the Groundwork for Better Pregnancy Drug Safety Evidence Read Post »
Mergers & AcquisitionsRoche to Acquire PathAI in Up to $1.05 Billion Digital Pathology Deal Roche to Acquire PathAI in Up to $1.05 Billion Digital Pathology Deal Read Post »
Health Tidings Mergers & AcquisitionsGSK Partners With Halozyme to Develop Subcutaneous ADC Therapies GSK Partners With Halozyme to Develop Subcutaneous ADC Therapies Read Post »
Health Tidings Mergers & AcquisitionsGSK Licenses SiranBio’s siRNA Candidate SA030 in Up to $1 Billion Deal GSK Licenses SiranBio’s siRNA Candidate SA030 in Up to $1 Billion Deal Read Post »
Health Tidings Mergers & AcquisitionsBayer to Acquire Perfuse Therapeutics in Up to USD 2.45 Billion Ophthalmolo... Bayer to Acquire Perfuse Therapeutics in Up to USD 2.45 Billion Ophthalmolo... Read Post »
Health Tidings Mergers & AcquisitionsHalozyme Licenses Hypercon Technology to Oruka Therapeutics for ORKA-001 Halozyme Licenses Hypercon Technology to Oruka Therapeutics for ORKA-001 Read Post »
Health Tidings Mergers & AcquisitionsArrowhead Takes Aim at MASH Genetics with Madrigal Licensing Deal Arrowhead Takes Aim at MASH Genetics with Madrigal Licensing Deal Read Post »
Health Tidings Mergers & AcquisitionsEvotec–Almirall Hit Preclinical Milestone for Skin Disease Therapy Evotec–Almirall Hit Preclinical Milestone for Skin Disease Therapy Read Post »
Health Tidings Mergers & AcquisitionsBioCryst and Neopharmed Gentili Sign Navenibart Deal to Support 2027 Filing BioCryst and Neopharmed Gentili Sign Navenibart Deal to Support 2027 Filing Read Post »
Mergers & AcquisitionsUCB Acquires Candid Therapeutics in $2.2 Billion Autoimmune Deal UCB Acquires Candid Therapeutics in $2.2 Billion Autoimmune Deal Read Post »
Health Tidings Mergers & AcquisitionsUCB Taps IMIDomics to Power Its Precision Medicine Engine UCB Taps IMIDomics to Power Its Precision Medicine Engine Read Post »
Regulatory & Health PolicyFDA Acts to Restrict Compounding of Popular GLP-1 Therapies from Bulk Subst... FDA Acts to Restrict Compounding of Popular GLP-1 Therapies from Bulk Subst... Read Post »
Regulatory & Health PolicyNICE Recommends Rozanolixizumab as New Option for Uncontrolled gMG NICE Recommends Rozanolixizumab as New Option for Uncontrolled gMG Read Post »
Mergers & AcquisitionsChiesi Seals a Strategic Win with $1.9B KalVista Acquisition Chiesi Seals a Strategic Win with $1.9B KalVista Acquisition Read Post »
